Amneal Pharmaceuticals (AMRX) Net Income Growth (3y) (2020 - 2026)
Amneal Pharmaceuticals (AMRX) Net Income Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 14.04% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -27.09% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 14.78% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 32.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.86% |
| Mar 31, 2026 | 113.29% |
| Dec 31, 2025 | 119.13% |
| Sep 30, 2025 | 112.43% |
| Jun 30, 2025 | 29.03% |
| Mar 31, 2025 | 79.78% |
| Dec 31, 2024 | -0.46% |
| Sep 30, 2024 | 58.02% |
| Jun 30, 2024 | -19.53% |
| Mar 31, 2024 | -96.88% |
| Dec 31, 2023 | -135.81% |
| Sep 30, 2023 | 46.37% |
| Jun 30, 2023 | 48.10% |
| Mar 31, 2023 | -27.72% |
| Dec 31, 2022 | 55.25% |
| Sep 30, 2022 | 81.27% |
| Jun 30, 2022 | -68.45% |
| Mar 31, 2022 | 62.77% |
| Dec 31, 2021 | 0.47% |
| Sep 30, 2021 | -32.87% |